Benzinga - Wed, 06 Jan 2021 09:27:36 -0400
Benzinga - Tue, 01 Dec 2020 09:45:48 -0400
Benzinga - Mon, 30 Nov 2020 07:57:48 -0400
Benzinga - Thu, 19 Nov 2020 08:02:19 -0400
Benzinga - Thu, 12 Nov 2020 05:18:15 -0400
Benzinga - Thu, 13 Aug 2020 16:12:11 -0400
Benzinga - Thu, 13 Aug 2020 04:03:29 -0400
Benzinga - Tue, 28 Jul 2020 05:07:14 -0400
Benzinga - Mon, 27 Jul 2020 12:22:54 -0400
Benzinga - Mon, 27 Jul 2020 07:04:23 -0400
Benzinga - Wed, 15 Jul 2020 04:49:19 -0400
load more
VolitionRX Ltd is a US-based multi-national life sciences company. It is engaged in developing easy to use blood-based tests to accurately diagnose a range of cancers. The development pipeline includes assays to be used for symptomatic patients or asymptomatic populations. The company has developed more than 30 blood-based assays to detect specific biomarkers. It also develops Nucleosomics tests for several major cancers including CRC, pancreatic, lung and aggressive prostate. In addition, the company engages in the process of developing HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help decide the appropriate therapy.

Earnings

see more
Q4 2020Est.ActualSurprise
EPS
(EXPECTED)2021-02-18
REV
Q3 2020Est.ActualSurprise
EPS-0.110-0.100 0.0100
REV1.250M575.000K-675.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
VNRXVolitionRX Limited Common Stock0.5%194.7M

VolitionRX Limited Common Stock Company Questions & Answers

Q

How do I buy VolitionRX Limited Common Stock (VNRX) stock?

A

You can purchase shares of VolitionRX Limited Common Stock (AMEX: VNRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are VolitionRX Limited Common Stock's (VNRX) main competitors?

A

There are no as such competitors for VolitionRX Limited Common Stock.

Q

What is the target price for VolitionRX Limited Common Stock?

A

The latest price target for VolitionRX Limited Common Stock (AMEX: VNRX) was reported by Aegis Capital on 2020-08-19. The analyst firm set a price target for 8.00 expecting VNRX to rise to within 12 months (a possible 98.02% upside). 2 analyst firms have reported ratings in the last year.

Q

How much is VolitionRX Limited Common Stock (VNRX) stock ?

A

The stock price for VolitionRX Limited Common Stock (AMEX: VNRX) is $4.04 last updated Fri Jan 15 2021 20:58:04 GMT+0000 (Coordinated Universal Time).

Q

When is the next VolitionRX Limited Common Stock (VNRX) dividend?

A

There are no upcoming dividends for VolitionRX Limited Common Stock.

Q

When is VolitionRX Limited Common Stock (AMEX:VNRX) reporting earnings?

A
VolitionRX Limited Common Stock’s Q4 earnings are confirmed from now on February 18, 2021.
Q

When is the upcoming split for VNRX?

A

There is no upcoming split for VolitionRX Limited Common Stock.